Form D · Biotechnology
Sapere Bio, Inc.
Durham, NC · CIK 0002032894
Offering snapshot reported Aug 12, 2024 · SEC filing
- Reported sold
- $500K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 25, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2024 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-521292
Simple Agreement for Future Equity
Source: Form D, filed Aug 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Natalia Mitin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 Park Offices Dr., Suite 113
Durham, NC, 27709
Durham, NC, 27709